NF-κB downstream miR-1262 disturbs colon cancer cell malignant behaviors by targeting FGFR1

Acta Biochim Biophys Sin (Shanghai). 2023 Nov 25;55(11):1819-1832. doi: 10.3724/abbs.2023235.

Abstract

Despite substantial advancements in screening, surgery, and chemotherapy, colorectal cancer remains the second most lethal form of the disease. Nuclear factor kappa B (NF-κB) signaling is a critical driver facilitating the malignant transformation of chronic inflammatory bowel diseases. In this study, deregulated miRNAs that could play a role in colon cancer are analyzed and investigated for specific functions in vitro using cancer cells and in vivo using a subcutaneous xenograft model. miRNA downstream targets are analyzed, and predicted binding and regulation are verified. miR-1262, an antitumor miRNA, is downregulated in colon cancer tissue samples and cell lines. miR-1262 overexpression suppresses colon cancer malignant behaviors in vitro and tumor development and metastasis in a subcutaneous xenograft model and a lung metastasis mouse model in vivo. miR-1262 directly targets fibroblast growth factor receptor 1 (FGFR1) and inhibits FGFR1 expression. FGFR1 overexpression shows oncogenic functions through the regulation of cancer cell proliferation, invasion, and migration; when cotransfected, lv-FGFR1 partially attenuates the antitumor effects of agomir-1262. NF-κB binds to the miR-1262 promoter region and inhibits transcription activity. The NF-κB inhibitor CAPE exerts antitumor effects; miR-1262 inhibition partially reverses CAPE effects on colon cancer cells. Conclusively, miR-1262 serves as an antitumor miRNA in colon cancer by targeting FGFR1. The NF-κB/miR-1262/FGFR1 axis modulates colon cancer cell phenotypes, including proliferation, invasion, and migration.

Keywords: NF-κB; colorectal cancer; fibroblast growth factor receptor 1 (FGFR1); miR-1262.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Colonic Neoplasms* / genetics
  • Disease Models, Animal
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mice
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Receptor, Fibroblast Growth Factor, Type 1 / genetics
  • Receptor, Fibroblast Growth Factor, Type 1 / metabolism

Substances

  • FGFR1 protein, human
  • MicroRNAs
  • NF-kappa B
  • Receptor, Fibroblast Growth Factor, Type 1
  • MIRN1262 microRNA, human

Grants and funding

This work was supported by the grants from the National Key Clinical Specialty Construction Project, China (No. 2022YW030009), the Natural Science Foundation of Guangdong Province, China (No. 2020A1515010573), the Natural Science Foundation of Hunan Province, China (No. 2019JJ40161), and the Hunan Provincial Health Commission Project (No. C2019060).